Salmeterol
Indications
Registered South African indications:
- Asthma
- Chronic obstructive pulmonary disease
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
Cautions
- Pregnancy
- Breastfeeding
- Hepatic impairment
- Acute asthma
- Cardiovascular disease
- Thyrotoxicosis
- Diabetes mellitus
- Hypokalaemia
- Lactose intolerance
- Concomitant use of systemic ketoconazole
- Patients with cognitive impairment (poor inhaler technique)
Adult dosage
Forms avail. in SA and covered in this monograph: acc, inh
Chronic asthma (Additional agent required)
Chronic obstructive pulmonary disease
- Inhaled (acc, inh): 50-100μg, 12hrly; Max: 200μg/24hrs
Not to be used as monotherapy in asthma (see additional prescribing points)
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: acc, inh
Chronic asthma (Additional agent required)
Younger than 4 years
- Not established for use
Older than 4 years
- Inhaled (acc, inh): 50μg, 12hrly; Max: 100μg/24hrs
Not to be used as monotherapy in asthma (see additional prescribing points)
Special populations
Pregnancy
- Caution
- A moderate amount of clinical data on pregnant women (between 300 to 1000 pregnancy outcomes) indicate no malformative or foetal/ neonatal toxicity of salmeterol. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity with the exception of evidence of some harmful effects on the foetus at very high dose levels. As a precautionary measure, it is preferable to avoid the use of salmeterol during pregnancy
Breastfeeding
- Caution
- Available pharmacodynamic/toxicological data in animals have shown excretion of salmeterol in milk. A risk to the suckling child cannot be excluded. A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from salmeterol therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the woman
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Central Nervous System Disorders
- Nervousness
- Insomnia
- Headache
- Tremor
- Dizziness
Cardiovascular Disorders
- Palpitations
- Tachycardia
- Arrhythmias
- Chest pain
Respiratory Disorders
- Oropharyngeal irritation
- Paradoxical bronchospasm
Gastrointestinal Disorders
- Nausea
Endocrine and Metabolic Disorders
- Hypokalaemia
- Hyperglycaemia
Musculoskeletal Disorders
- Muscle cramps
- Arthralgia
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity reactions
- Anaphylactic reactions
- Anaphylactic shock
Interactions
- Beta blockers
- Xanthine derivatives
- Steroids
- Diuretics
- CYP3A4 inhibitors
- CYP3A4 inhibitors
Monitoring
None routine. Specific cases may require
- Serum potassium
- Blood glucose
- Vital signs
Prescribing points
- Patients with asthma should never be on a long-acting beta agonist (such as Salmeterol or Formoterol) without an inhaled corticosteroid
- Salmeterol Accuhaler should be used regularly. The full benefits of treatment will be apparent after several doses of the drug
Mechanism of action
Salmeterol is a selective long-acting beta-2 adrenoceptor agonist with a long side chain which binds to the exo-site of the receptors in the lungs and on bronchiolar smooth muscle. This causes relaxation of bronchial smooth muscle, bronchodilation and increased bronchial airflow.
Dosage forms
- Inhaler
- Accuhaler
Formulation
Inhaler 25μg
- Serevent Inhaler CFC-Free (Aspen) originator
Accuhaler 50μg
- Serevent Accuhaler (GSK) originator
COMBINATION PREPARATIONS
Salmeterol/ Fluticasone propionate
Inhaler 25μg/50μg
- Sereflo 25/50 Hfa (Cipla)
- Foxair inhaler (Aspen) originator
- Seretide CFC inhaler (GSK)
Inhaler 25μg/125μg
- Sereflo 25/125 Hfa (Cipla)
- Foxair inhaler (Aspen) originator
- Seretide CFC inhaler (GSK)
Inhaler 25μg/250μg
- Sereflo 25/250 Hfa (Cipla)
- Foxair inhaler (Aspen) originator
- Seretide CFC inhaler (GSK)
Accuhaler 50μg/100μg
- Foxair Accuhaler (Aspen)
- Seretide Accuhaler (GSK)
Accuhaler 50μg/250μg
- Foxair Accuhaler (Aspen)
- Seretide Accuhaler (GSK)
Accuhaler 50μg/500μg
- Foxair Accuhaler (Aspen)
- Seretide Accuhaler (GSK)
References
1. SAMF_12th Edition_Pge 550 2. SmPC: Serevent Accuhaler, GlaxoSmithKline UK: Last updated on eMC: 02 Oct 2018; Downloaded online; 25 Nov 2018 [https://www.medicines.org.uk/emc/medicine/91] 3. https://drive.google.com/drive/folders/0B0xnChtF7vdua0lHaFhJbmd1cUk (15/09/2006_Aspen_Serevent_inh 25mcg) 4. https://drive.google.com/drive/folders/0B0xnChtF7vdua0lHaFhJbmd1cUk (18/08/1995_GSK_Serevent_acc 50mcg) 5. SmPC: Serevent Evohaler, GlaxoSmithKline UK: Last updated on eMC: 02 Oct 2018; Downloaded online; 25 Nov 2018 [https://www.medicines.org.uk/emc/medicine/17201] 6. U2D: Salmeterol: Drug information; Uptodate; Downloaded online; 25 Nov 2018 https://www.uptodate.com/contents/salmeterol-drug-information?search=salmeterol&source=panel_search_result&selectedTitle=1~80&usage_type=panel&kp_tab=drug_general&display_rank=1 7. NAPOS The Drug Database for Acute Porphyria: Salmeterol; Accessed online; 20 Nov 2018 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=R03AC12&l=gbr] 8. South African Institute for Drug-Free Sport: Serevent; Accessed online; 20 Nov 2018 [http://www.drugfreesport.org.za/online-medication-check/ 9. SmPC: Serevent Accuhaler, GlaxoSmithKline UK: Last updated on eMC: 29 Nov 2019; Downloaded online; 8 Apr 2020 [https://drive.google.com/drive/folders/1nHE7j17r0pBDedsx5zTrNNqqzGms9MdD]
Brands & products
17 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days oldinhalerGeneric· 6 products
from R2.01/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Sereflo 25/50 hfa synchrobreathe 120 dos | 25 µg | 120 | S4 | R241.69 | R2.01 | R91.70 | 721412001 |
| Sereflo 25/125 hfa synchrobreathe 120 do | 25 µg | 120 | S4 | R314.19 | R2.62 | R111.64 | 721413001 |
| Sereflo 25/250 hfa synchrobreathe 120 do | 25 µg | 120 | S4 | R410.63 | R3.42 | R138.17 | 721414001 |
| Foxair 25/50 120 dose | 50 mcg | 120 | S4 | R414.59 | R3.45 | R139.26 | 715752001 |
| Foxair 25/125 120dose | 125 mcg | 120 | S4 | R532.88 | R4.44 | R162.86 | 715753001 |
| Serevent cfc-free 120dose | 25 mcg | 120 | S2 | R797.40 | R6.64 | R201.77 | 708289001 |
solutionGeneric· 1 product
from R2.66/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Keppra | 50 mcg | 300 | S3 | R796.85 | R2.66 | R201.69 | 714166001 |
AccGeneric· 8 products
from R5.71/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Airflusal Forspiro 50/250 | 250 mcg | 60 | S4 | R342.76 | R5.71 | R119.50 | 3004879001 |
| Casorol Casometer 50/250 Μg | 250 mcg | 60 | S4 | R363.67 | R6.06 | R125.26 | 3005769001 |
| Foxair accuhaler 60 dose 50/100 | 100 mcg | 60 | S4 | R467.02 | R7.78 | R153.69 | 715009001 |
| Airflusal Forspiro 50/500 | 500 mcg | 60 | S4 | R505.11 | R8.42 | R158.77 | 3004880001 |
| Casorol Casometer 50/500 Μg | 500 mcg | 60 | S4 | R532.69 | R8.88 | R162.83 | 3005772001 |
| Foxair accuhaler 60 dose 50/250 | 250 mcg | 60 | S4 | R533.66 | R8.89 | R162.97 | 715008001 |
| Foxair accuhaler 60 dose 50/500 | 500 mcg | 60 | S4 | R720.05 | R12.00 | R190.39 | 715007001 |
| Serevent accuhaler 60dose | 50 mcg | 60 | S4 | R797.40 | R13.29 | R201.77 | 818496002 |
suspensionGeneric· 1 product
from R25.71/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Wellvone | 50 mcg | 210 | S4 | R5398.70 | R25.71 | R509.26 | 864587008 |
KitGeneric· 1 product
from R132.75/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Relenza | 25 mcg | 5 | S4 | R663.77 | R132.75 | R182.11 | 888609002 |
- Serevent
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
Interacts with 8 known drugs
Check against other drugs →Cited in 12 documents
- GuidelinesPersistent Asthma10×
- GuidelinesTreatment: Available Therapies4×
- GuidelinesChronic Obstructive Pulmonary Disease (COPD)2×
- GuidelinesReferences2×
- GuidelinesReferences - Respiratory Conditions2×
- GuidelinesReferences - SATS Asthma2×
- GuidelinesAsthma
- GuidelinesAsthma, Chronic Persistent
- GuidelinesBreathlessness
- GuidelinesChronic Asthma
- GuidelinesChronic Asthma
- GuidelinesChronic Obstructive Pulmonary Disease (COPD)